Cargando…

Dystrophin deficiency exacerbates skeletal muscle pathology in dysferlin-null mice

BACKGROUND: Mutations in the genes coding for either dystrophin or dysferlin cause distinct forms of muscular dystrophy. Dystrophin links the cytoskeleton to the sarcolemma through direct interaction with β-dystroglycan. This link extends to the extracellular matrix by β-dystroglycan's interact...

Descripción completa

Detalles Bibliográficos
Autores principales:	Han, Renzhi, Rader, Erik P, Levy, Jennifer R, Bansal, Dimple, Campbell, Kevin P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3287108/ https://www.ncbi.nlm.nih.gov/pubmed/22132688 http://dx.doi.org/10.1186/2044-5040-1-35

Ejemplares similares

GRAF1 deficiency blunts sarcolemmal injury repair and exacerbates cardiac and skeletal muscle pathology in dystrophin-deficient mice
por: Lenhart, Kaitlin C., et al.
Publicado: (2015)

Comparison of Dysferlin Expression in Human Skeletal Muscle with That in Monocytes for the Diagnosis of Dysferlin Myopathy
por: Gallardo, Eduard, et al.
Publicado: (2011)

Equal Force Recovery in Dysferlin-Deficient and Wild-Type Muscles Following Saponin Exposure
por: Zhao, Piming, et al.
Publicado: (2011)

Elevated Ca(2+) at the triad junction underlies dysregulation of Ca(2+) signaling in dysferlin-null skeletal muscle
por: Lukyanenko, Valeriy, et al.
Publicado: (2022)

Effects of Mini-Dystrophin on Dystrophin-Deficient, Human Skeletal Muscle-Derived Cells
por: Meng, Jinhong, et al.
Publicado: (2020)

Dysferlin Interacts with Tubulin and Microtubules in Mouse Skeletal Muscle
por: Azakir, Bilal A., et al.
Publicado: (2010)

Full-length Dysferlin Transfer by the Hyperactive Sleeping Beauty Transposase Restores Dysferlin-deficient Muscle
por: Escobar, Helena, et al.
Publicado: (2016)

Dysferlin at transverse tubules regulates Ca(2+) homeostasis in skeletal muscle
por: Kerr, Jaclyn P., et al.
Publicado: (2014)

Collagen VI deficiency reduces muscle pathology, but does not improve muscle function, in the γ-sarcoglycan-null mouse
por: de Greef, Jessica C., et al.
Publicado: (2016)

Characterization of Dysferlin Deficient SJL/J Mice to Assess Preclinical Drug Efficacy: Fasudil Exacerbates Muscle Disease Phenotype
por: Rayavarapu, Sree, et al.
Publicado: (2010)

Comparative Gene Expression Analysis in the Skeletal Muscles of Dysferlin-deficient SJL/J and A/J Mice
por: Kobayashi, Kinji, et al.
Publicado: (2011)

Blockade of Hemichannels Normalizes the Differentiation Fate of Myoblasts and Features of Skeletal Muscles from Dysferlin-Deficient Mice
por: Cea, Luis A., et al.
Publicado: (2020)

Contribution of Dysferlin Deficiency to Skeletal Muscle Pathology in Asymptomatic and Severe Dystroglycanopathy Models: Generation of a New Model for Fukuyama Congenital Muscular Dystrophy
por: Kanagawa, Motoi, et al.
Publicado: (2014)

Chemical crosslinking analysis of β-dystroglycan in dystrophin-deficient skeletal muscle
por: Murphy, Sandra, et al.
Publicado: (2018)

Inhibition of the immunoproteasome modulates innate immunity to ameliorate muscle pathology of dysferlin-deficient BlAJ mice
por: Farini, A., et al.
Publicado: (2022)

Muscular dystrophy with marked Dysferlin deficiency is consistently caused by primary dysferlin gene mutations
por: Cacciottolo, Mafalda, et al.
Publicado: (2011)

Genetic silencing of Nrf2 enhances X-ROS in dysferlin-deficient muscle
por: Kombairaju, Ponvijay, et al.
Publicado: (2014)

Dystrophin deficiency reduces atherosclerotic plaque development in ApoE-null mice
por: Shami, Annelie, et al.
Publicado: (2015)

Diltiazem improves contractile properties of skeletal muscle in dysferlin‐deficient BLAJ mice, but does not reduce contraction‐induced muscle damage
por: Begam, Morium, et al.
Publicado: (2018)

Destabilization of the Dystrophin-Glycoprotein Complex without Functional Deficits in α-Dystrobrevin Null Muscle
por: Bunnell, Tina M., et al.
Publicado: (2008)

N-Acetylcysteine Reduces Skeletal Muscles Oxidative Stress and Improves Grip Strength in Dysferlin-Deficient Bla/J Mice
por: García-Campos, Paz, et al.
Publicado: (2020)

Investigations of an inducible intact dystrophin gene excision system in cardiac and skeletal muscle in vivo
por: Bez Batti Angulski, Addeli, et al.
Publicado: (2020)

Genetic characterization and improved genotyping of the dysferlin-deficient mouse strain Dysf(tm1Kcam)
por: Wiktorowicz, Tatiana, et al.
Publicado: (2015)

Loss of peroxiredoxin-2 exacerbates eccentric contraction-induced force loss in dystrophin-deficient muscle
por: Olthoff, John T., et al.
Publicado: (2018)

Attenuated muscle regeneration is a key factor in dysferlin-deficient muscular dystrophy
por: Chiu, Yen-Hui, et al.
Publicado: (2009)

Sildenafil ameliorates cardiomyopathy in dystrophin-null (mdx) mice
por: Parchen, Candace M, et al.
Publicado: (2009)

Autophagy is Impaired in the Tibialis Anterior of Dystrophin Null Mice
por: Spitali, Pietro, et al.
Publicado: (2013)

Glycine administration attenuates progression of dystrophic pathology in prednisolone-treated dystrophin/utrophin null mice
por: Ham, Daniel J., et al.
Publicado: (2019)

Loss of dysferlin or myoferlin results in differential defects in excitation–contraction coupling in mouse skeletal muscle
por: Barefield, David Y., et al.
Publicado: (2021)

The muscle protein dysferlin accumulates in the Alzheimer brain
por: Galvin, James E., et al.
Publicado: (2006)

Quantitative immuno-mass spectrometry imaging of skeletal muscle dystrophin
por: Bishop, David P., et al.
Publicado: (2021)

Dysferlin-Peptides Reallocate Mutated Dysferlin Thereby Restoring Function
por: Schoewel, Verena, et al.
Publicado: (2012)

Angiotensin II receptor blocker losartan exacerbates muscle damage and exhibits weak blood pressure-lowering activity in a dysferlin-null model of Limb-Girdle muscular dystrophy type 2B
por: White, Zoe, et al.
Publicado: (2019)

Evaluation of Skeletal and Cardiac Muscle Function after Chronic Administration of Thymosin β-4 in the Dystrophin Deficient Mouse
por: Spurney, Christopher F., et al.
Publicado: (2010)

Cholesterol absorption blocker ezetimibe prevents muscle wasting in severe dysferlin‐deficient and mdx mice
por: White, Zoe, et al.
Publicado: (2021)

Fetal Skeletal Muscle Progenitors Have Regenerative Capacity after Intramuscular Engraftment in Dystrophin Deficient Mice
por: Sakai, Hiroshi, et al.
Publicado: (2013)

Rapid restitution of contractile dysfunction by synthetic copolymers in dystrophin-deficient single live skeletal muscle fibers
por: Hahn, Dongwoo, et al.
Publicado: (2023)

The subcellular distribution of dystrophin in mouse skeletal, cardiac, and smooth muscle
Publicado: (1991)

Direct visualization of the dystrophin network on skeletal muscle fiber membrane
Publicado: (1992)

Dystrophin and mini-dystrophin quantification by mass spectrometry in skeletal muscle for gene therapy development in Duchenne muscular dystrophy
por: Farrokhi, Vahid, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_55rm5c136nm6fl4ofh1alcmelc